Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Tonix Pharmaceuticals Holding (TNXP) FCF Margin: 2023-2025

Historic FCF Margin for Tonix Pharmaceuticals Holding (TNXP) over the last 2 years, with Sep 2025 value amounting to -904.07%.

  • Tonix Pharmaceuticals Holding's FCF Margin fell 23752.00% to -904.07% in Q3 2025 from the same period last year, while for Sep 2025 it was -741.06%, marking a year-over-year decrease of 12827.00%. This contributed to the annual value of -604.77% for FY2024, which is 80999.00% up from last year.
  • As of Q3 2025, Tonix Pharmaceuticals Holding's FCF Margin stood at -904.07%, which was down 17.60% from -768.77% recorded in Q2 2025.
  • Tonix Pharmaceuticals Holding's 5-year FCF Margin high stood at -449.23% for Q2 2024, and its period low was -904.07% during Q3 2025.
  • Over the past 3 years, Tonix Pharmaceuticals Holding's median FCF Margin value was -666.55% (recorded in 2024), while the average stood at -665.00%.
  • Its FCF Margin has fluctuated over the past 5 years, first skyrocketed by 3,602bps in 2024, then plummeted by 31,954bps in 2025.
  • Over the past 3 years, Tonix Pharmaceuticals Holding's FCF Margin (Quarterly) stood at -602.75% in 2023, then skyrocketed by 3,602bps to -566.73% in 2024, then tumbled by 23,752bps to -904.07% in 2025.
  • Its FCF Margin stands at -904.07% for Q3 2025, versus -768.77% for Q2 2025 and -682.79% for Q1 2025.